Selection of smart aptamers by methods of kinetic capillary electrophoresis

Analytical Chemistry
Andrei P DrabovichSergey N Krylov

Abstract

We coin the term "smart aptamers" -- aptamers with predefined binding parameters (k(on), k(off), Kd) of aptamer-target interaction. Aptamers, in general, are oligonucleotides, which are capable of binding target molecules with high affinity and selectivity. They are considered as potential therapeutic targets and also thought to rival antibodies in immunoassay-like analyses. Aptamers are selected from combinatorial libraries of oligonucleotides by affinity methods. Until now, technological limitations have precluded the development of smart aptamers. Here, we report on two kinetic capillary electrophoresis techniques applicable to the selection of smart aptamers. Equilibrium capillary electrophoresis of equilibrium mixtures was used to develop aptamers with predefined equilibrium dissociation constants (Kd), while nonequilibrium capillary electrophoresis of equilibrium mixtures facilitated selection of aptamers with different dissociation rate constants (k(off)). Selections were made for MutS protein, for which aptamers have never been previously developed. Both theoretical and practical aspects of smart aptamer development are presented, and the advantages of this new type of affinity probes are described.

References

Aug 30, 1990·Nature·A D Ellington, J W Szostak
Feb 28, 1995·Proceedings of the National Academy of Sciences of the United States of America·J Foote, H N Eisen
Jun 29, 2000·Annual Review of Biochemistry·D S Wilson, J W Szostak
Sep 20, 2000·Accounts of Chemical Research·M FamulokM Blind
May 18, 2001·BioTechniques·L S GreenN Janjic
Nov 10, 2001·Annual Review of Biomedical Engineering·J Maynard, G Georgiou
Mar 14, 2003·Trends in Biochemical Sciences·Terry T TakahashiRichard W Roberts
Oct 3, 2003·Chembiochem : a European Journal of Chemical Biology·Martina Rimmele
Dec 9, 2003·Electrophoresis·Niels H H Heegaard
Jan 8, 2004·Journal of the American Chemical Society·Shaun D Mendonsa, Michael T Bowser
Mar 5, 2004·Proteomics·Chris BockDominic Zichi
Aug 10, 2004·Chembiochem : a European Journal of Chemical Biology·Razvan NutiuYingfu Li
Nov 13, 2004·Proteomics·Richard Barry, Mikhail Soloviev
Dec 2, 2004·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Günter Mayer, Andreas Jenne
Jan 8, 2005·Chembiochem : a European Journal of Chemical Biology·Michael Famulok, Günter Mayer
Jan 22, 2005·Annual Review of Medicine·Shahid M NimjeeBruce A Sullenger
Feb 11, 2005·Analytical and Bioanalytical Chemistry·Melissa Gayton-ElyLisa A Holland
Mar 1, 2005·Trends in Biotechnology·Eric A Davidson, Andrew D Ellington
Mar 3, 2005·Journal of the American Chemical Society·Maxim BerezovskiSergey N Krylov
Apr 28, 2005·Biosensors & Bioelectronics·S TombelliM Mascini
Jun 21, 2005·Biochimie·C PestourieF Duconge
Jul 12, 2005·Current Opinion in Chemical Biology·Michael Blank, Michael Blind
Aug 11, 2005·Journal of the American Chemical Society·Andrei DrabovichSergey N Krylov
Sep 9, 2005·The AAPS Journal·Siddhesh D PatilDiane J Burgess
Nov 12, 2005·Applied Microbiology and Biotechnology·Daniela ProskeAnsgar Resch
Dec 1, 2005·Journal of the American Chemical Society·Alexander PetrovSergey N Krylov
Feb 2, 2006·Journal of the American Chemical Society·Maxim BerezovskiSergey N Krylov

❮ Previous
Next ❯

Citations

May 20, 2008·Analytical Chemistry·Vratislav KostalEdgar A Arriaga
Mar 24, 2009·Chemical Reviews·Juewen LiuYi Lu
Dec 25, 2010·Oligonucleotides·Jiehua Zhou, John J Rossi
Nov 15, 2012·Journal of Nucleic Acids·Maureen McKeague, Maria C Derosa
Nov 8, 2014·Biomicrofluidics·Hui LinZhi Zhu
Nov 13, 2012·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Padma SundaramJacek Wower
Jul 19, 2011·Sensors and Actuators. B, Chemical·Thai Huu NguyenQiao Lin
Jul 14, 2007·Biomolecular Engineering·Regina StoltenburgBeate Strehlitz
Jan 18, 2011·Analytica Chimica Acta·Meng Jing, Michael T Bowser
Feb 24, 2015·Journal of Pharmaceutical and Biomedical Analysis·Xiwei ZhengDavid S Hage
Sep 18, 2013·Artificial DNA, PNA & XNA·Masayasu Kuwahara, Satoshi Obika
Mar 1, 2012·Analytical Biochemistry·Sung-Eun KimWoo-Seok Choe
Dec 25, 2012·Biophysical Journal·Michael J Saxton
Jan 13, 2015·Analytical and Bioanalytical Chemistry·Kathryn R RileyKeith Bonin
May 26, 2016·Methods : a Companion to Methods in Enzymology·Florian Groher, Beatrix Suess
Sep 14, 2010·Journal of the American Chemical Society·Michael U MusheevSergey N Krylov
Jul 7, 2011·Analytical Chemistry·Stephanie de Jong, Sergey N Krylov
Jul 14, 2017·Biomedicines·David E Volk, Ganesh L R Lokesh
Oct 27, 2017·International Journal of Molecular Sciences·Maureen McKeague
Nov 28, 2012·Nucleic Acid Therapeutics·Kasper K Karlsen, Jesper Wengel
Jan 25, 2007·Electrophoresis·Sergey N Krylov
Jul 12, 2007·Journal of Separation Science·Renee K Mosing, Michael T Bowser
Nov 28, 2007·Electrophoresis·Eun Joo SongYoung Sook Yoo
Aug 11, 2015·Macromolecular Bioscience·Elizabeth G WhittyPatrice Castignolles

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of the American Chemical Society
Maxim BerezovskiSergey N Krylov
Journal of the American Chemical Society
Shaun D Mendonsa, Michael T Bowser
© 2022 Meta ULC. All rights reserved